{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T07:46:08Z","timestamp":1785829568594,"version":"3.56.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016275","name":"Seoul National University Bundang Hospital","doi-asserted-by":"publisher","award":["06-2023-0016"],"award-info":[{"award-number":["06-2023-0016"]}],"id":[{"id":"10.13039\/100016275","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Korea National Institute of Health-Funded Research Program","award":["2016ER670100, 2016ER670101, 2016ER670102, 2018ER67100, 2018ER67101, 2018ER67102, 2021ER120500, 2021ER120501, 2021ER120502, 2024ER120500, and 2024ER120501)."],"award-info":[{"award-number":["2016ER670100, 2016ER670101, 2016ER670102, 2018ER67100, 2018ER67101, 2018ER67102, 2021ER120500, 2021ER120501, 2021ER120502, 2024ER120500, and 2024ER120501)."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The relationship between smoking and blood viscosity is well established. However, the role of blood viscosity in the development of chronic obstructive pulmonary disease (COPD) and its impact on lung function decline remains unclear. Therefore, we aimed to investigate the association of blood viscosity with COPD and lung function decline, independent of smoking status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from 292 participants in the Korea COPD Subgroup Study (KOCOSS), a multicenter prospective cohort, were analyzed. Subjects were classified into four groups based on smoking history and COPD status. Multiple linear regression analysis was performed to determine the association between baseline viscosity and lung function decline after adjusting for age, sex, smoking status, and COPD status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 292 participants, 93 (31.8%) patients had COPD. Ever smokers with or without COPD were older than never smokers and predominantly male. Never smokers with COPD reported the highest scores for the Modified Medical Research Council Dyspnea Scale. Blood viscosity was significantly higher in ever smokers (with COPD: 9.0\u2009\u00b1\u20091.4; without COPD 9.2\u2009\u00b1\u20091.5) than in never smokers (with COPD: 8.7\u2009\u00b1\u20091.8; without COPD: 8.4\u2009\u00b1\u20091.5). Viscosity did not differ significantly with the presence of COPD within the same smoking category. Adjusted multiple linear regression revealed that baseline blood viscosity was not associated with 2-year declines in forced expiratory volume in 1\u00a0s (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.557), forced vital capacity (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.686), or diffusing capacity of the lung for carbon monoxide (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.947).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Blood viscosity appeared to be more closely associated with smoking-related hemorheological changes than with COPD. Its potential as a predictive biomarker for lung function decline appears to be limited, necessitating further long-term investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-026-03827-8","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:56:54Z","timestamp":1785826614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Blood viscosity is associated with smoking status rather than the presence of chronic obstructive pulmonary disease: findings from the Korea COPD Subgroup Study (KOCOSS)"],"prefix":"10.1186","volume":"27","author":[{"given":"Ye Jin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Rin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hyuk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Seung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Kyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Ha","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlim","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"issue":"2","key":"3827_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S2213-2600(23)00340-5","volume":"12","author":"J Zhang","year":"2024","unstructured":"Zhang J, Lodge CJ, Walters EH, Chang AB, Bui DS, Lowe AJ, et al. Association of novel adult cough subclasses with clinical characteristics and lung function across six decades of life in a prospective, community-based cohort in Australia: an analysis of the Tasmanian Longitudinal Health Study (TAHS). Lancet Respiratory Med. 2024;12(2):129\u201340.","journal-title":"Lancet Respiratory Med"},{"issue":"1","key":"3827_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1465-9921-12-129","volume":"12","author":"S Kesten","year":"2011","unstructured":"Kesten S, Celli B, Decramer M, Liu D, Tashkin D. Adverse health consequences in COPD patients with rapid decline in FEV1 - evidence from the UPLIFT trial. Respir Res. 2011;12(1):129.","journal-title":"Respir Res"},{"issue":"10","key":"3827_CR3","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jacc.2018.06.049","volume":"72","author":"OM Silvestre","year":"2018","unstructured":"Silvestre OM, Nadruz W, Querejeta Roca G, Claggett B, Solomon SD, Mirabelli MC, et al. Declining lung function and cardiovascular risk: the ARIC study. J Am Coll Cardiol. 2018;72(10):1109\u201322.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"3827_CR4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1164\/rccm.201605-1014OC","volume":"195","author":"MT Dransfield","year":"2017","unstructured":"Dransfield MT, Kunisaki KM, Strand MJ, Anzueto A, Bhatt SP, Bowler RP, et al. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2017;195(3):324\u201330.","journal-title":"Am J Respir Crit Care Med"},{"key":"3827_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.rmed.2017.04.013","volume":"128","author":"DMG Halpin","year":"2017","unstructured":"Halpin DMG, Decramer M, Celli BR, Mueller A, Metzdorf N, Tashkin DP. Effect of a single exacerbation on decline in lung function in COPD. Respir Med. 2017;128:85\u201391.","journal-title":"Respir Med"},{"issue":"2","key":"3827_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1411532","volume":"373","author":"P Lange","year":"2015","unstructured":"Lange P, Celli B, Agust\u00ed A, Boje Jensen G, Divo M, Faner R, et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med. 2015;373(2):111\u201322.","journal-title":"N Engl J Med"},{"issue":"25","key":"3827_CR7","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1056\/NEJM199906243402503","volume":"340","author":"RA Pauwels","year":"1999","unstructured":"Pauwels RA, L\u00f6fdahl CG, Laitinen LA, Schouten JP, Postma DS, Pride NB, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med. 1999;340(25):1948\u201353.","journal-title":"N Engl J Med"},{"key":"3827_CR8","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.2147\/COPD.S278981","volume":"15","author":"HR Whittaker","year":"2020","unstructured":"Whittaker HR, Pimenta JM, Jarvis D, Kiddle SJ, Quint JK. Characteristics Associated with Accelerated Lung Function Decline in a Primary Care Population with Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2020;15:3079\u201391.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"3827_CR9","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of COPD: Global Initiative for Chronic Obstructive Lung Disease; 2024. Available from: https:\/\/goldcopd.org\/2024-gold-report\/."},{"issue":"1","key":"3827_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2169\/internalmedicine.9339-22","volume":"62","author":"T Hirano","year":"2023","unstructured":"Hirano T, Matsunaga K. Measurement of Blood Eosinophils in Asthma and Chronic Obstructive Pulmonary Disease. Intern Med. 2023;62(1):21\u20135.","journal-title":"Intern Med"},{"issue":"5","key":"3827_CR11","doi-asserted-by":"publisher","first-page":"e37483","DOI":"10.1371\/journal.pone.0037483","volume":"7","author":"A Agust\u00ed","year":"2012","unstructured":"Agust\u00ed A, Edwards LD, Rennard SI, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS ONE. 2012;7(5):e37483.","journal-title":"PLoS ONE"},{"issue":"1","key":"3827_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","volume":"138","author":"PJ Barnes","year":"2016","unstructured":"Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16\u201327.","journal-title":"J Allergy Clin Immunol"},{"issue":"6\u20137","key":"3827_CR13","first-page":"347","volume":"20","author":"DM Mannino","year":"2015","unstructured":"Mannino DM, Tal-Singer R, Lomas DA, et al. Blood biomarkers and clinical outcomes in chronic obstructive pulmonary disease: a systematic review. Biomarkers. 2015;20(6\u20137):347\u201356.","journal-title":"Biomarkers"},{"issue":"3","key":"3827_CR14","first-page":"e36100","volume":"15","author":"S Tariq","year":"2023","unstructured":"Tariq S, Ismail D, Thapa M, Goriparthi L, Pradeep R, Khalid K, et al. Chronic Obstructive Pulmonary Disease and Its Effect on Red Blood Cell Indices. Cureus. 2023;15(3):e36100.","journal-title":"Cureus"},{"issue":"2","key":"3827_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1164\/rccm.202110-2353ED","volume":"205","author":"M van den Berge","year":"2022","unstructured":"van den Berge M, Faiz A. Transcriptome-based Signatures: The Future Biomarkers in Obstructive Pulmonary Diseases Such as Asthma and Chronic Obstructive Pulmonary Disease? Am J Respir Crit Care Med. 2022;205(2):139\u201340.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"3827_CR16","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s10654-016-0132-z","volume":"31","author":"N Terzikhan","year":"2016","unstructured":"Terzikhan N, Verhamme KM, Hofman A, Stricker BH, Brusselle GG, Lahousse L. Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study. Eur J Epidemiol. 2016;31(8):785\u201392.","journal-title":"Eur J Epidemiol"},{"issue":"10356","key":"3827_CR17","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0140-6736(22)01273-9","volume":"400","author":"D Stolz","year":"2022","unstructured":"Stolz D, Mkorombindo T, Schumann DM, Agusti A, Ash SY, Bafadhel M, et al. Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission. Lancet. 2022;400(10356):921\u201372.","journal-title":"Lancet"},{"key":"3827_CR18","doi-asserted-by":"publisher","first-page":"201179","DOI":"10.1016\/j.humgen.2023.201179","volume":"36","author":"A Sahu","year":"2023","unstructured":"Sahu A, Kumar S, Kant S, Mishra S, Banerjee M. Genetic biomarkers for risk prediction of chronic obstructive pulmonary disease (COPD) in smokers and non-smokers. Hum Gene. 2023;36:201179.","journal-title":"Hum Gene"},{"key":"3827_CR19","doi-asserted-by":"publisher","first-page":"101544","DOI":"10.1016\/j.redox.2020.101544","volume":"33","author":"PJ Barnes","year":"2020","unstructured":"Barnes PJ. Oxidative stress-based therapeutics in COPD. Redox Biol. 2020;33:101544.","journal-title":"Redox Biol"},{"key":"3827_CR20","doi-asserted-by":"publisher","unstructured":"Barnes PJ. Oxidative Stress in Chronic Obstructive Pulmonary Disease. Antioxid (Basel). 2022;11(5):965. https:\/\/doi.org\/10.3390\/antiox11050965.","DOI":"10.3390\/antiox11050965"},{"key":"3827_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2147\/COPD.S42414","volume":"10","author":"BM Fischer","year":"2015","unstructured":"Fischer BM, Voynow JA, Ghio AJ. COPD: balancing oxidants and antioxidants. Int J Chron Obstruct Pulmon Dis. 2015;10:261\u201376.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"3827_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/ajh.26440","volume":"97","author":"E Nader","year":"2022","unstructured":"Nader E, Nougier C, Boisson C, Poutrel S, Catella J, Martin F, et al. Increased blood viscosity and red blood cell aggregation in patients with COVID-19. Am J Hematol. 2022;97(3):283\u201392.","journal-title":"Am J Hematol"},{"issue":"8","key":"3827_CR23","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3390\/biom13081262","volume":"13","author":"F Orrico","year":"2023","unstructured":"Orrico F, Laurance S, Lopez AC, Lefevre SD, Thomson L, M\u00f6ller MN, et al. Oxidative Stress in Healthy and Pathological Red Blood Cells. Biomolecules. 2023;13(8):1262.","journal-title":"Biomolecules"},{"issue":"1","key":"3827_CR24","first-page":"1286263","volume":"2017","author":"E Ugurlu","year":"2017","unstructured":"Ugurlu E, Kilic-Toprak E, Can I, Kilic-Erkek O, Altinisik G, Bor-Kucukatay M. Impaired hemorheology in exacerbations of COPD. Can Respir J. 2017;2017(1):1286263.","journal-title":"Can Respir J"},{"issue":"1","key":"3827_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2213-0802-1-3","volume":"1","author":"G Cakmak","year":"2013","unstructured":"Cakmak G, Alkan FA, Korkmaz K, Saglam ZA, Karis D, Yenigun M, et al. Blood viscosity as a forgotten factor and its effect on pulmonary flow. Transl Respir Med. 2013;1(1):3.","journal-title":"Transl Respir Med"},{"issue":"5","key":"3827_CR26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1055\/s-2003-44551","volume":"29","author":"OK Baskurt","year":"2003","unstructured":"Baskurt OK, Meiselman HJ. Blood rheology and hemodynamics. Semin Thromb Hemost. 2003;29(5):435\u201350.","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"3827_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3233\/CH-152018","volume":"63","author":"DD Ergun","year":"2016","unstructured":"Ergun DD, Karis D, Alkan FA, Cakmak G, Yenigun M, Ercan M. Effects of cigarette smoking on hemorheologic parameters, plasma osmolality and lung function. Clin Hemorheol Microcirc. 2016;63(4):313\u201324.","journal-title":"Clin Hemorheol Microcirc"},{"issue":"1\u20132","key":"3827_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.clinbiochem.2012.10.015","volume":"46","author":"H Kim","year":"2013","unstructured":"Kim H, Cho YI, Lee D-H, Park C-M, Moon H-W, Hur M, et al. Analytical performance evaluation of the scanning capillary tube viscometer for measurement of whole blood viscosity. Clin Biochem. 2013;46(1\u20132):139\u201342.","journal-title":"Clin Biochem"},{"key":"3827_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.polymertesting.2018.06.034","volume":"70","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Huang M, Kan Y, Liu L, Dai X, Zheng G, et al. Influencing factors of viscosity measurement by rotational method. Polym Test. 2018;70:144\u201350.","journal-title":"Polym Test"},{"issue":"1","key":"3827_CR30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1253\/circj.CJ-10-0335","volume":"75","author":"S Shimada","year":"2011","unstructured":"Shimada S, Hasegawa K, Wada H, Terashima S, Satoh-Asahara N, Yamakage H, et al. High blood viscosity is closely associated with cigarette smoking and markedly reduced by smoking cessation. Circ J. 2011;75(1):185\u20139.","journal-title":"Circ J"},{"issue":"1","key":"3827_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/003693308002500103","volume":"25","author":"G Lowe","year":"1980","unstructured":"Lowe G, Drummond M, Forbes C, Barbenel J. The effects of age and cigarette-smoking on blood and plasma viscosity in men. Scot Med J. 1980;25(1):13\u20137.","journal-title":"Scot Med J"},{"issue":"6","key":"3827_CR32","first-page":"759","volume":"7","author":"G Szendro","year":"1988","unstructured":"Szendro G, Golcman L, Cristal N. Study of the factors affecting blood viscosity in patients with thromboangiitis obliterans. A preliminary report. J Vasc Surg. 1988;7(6):759\u201362.","journal-title":"J Vasc Surg"},{"key":"3827_CR33","unstructured":"Verbitski\u012d ON, Buturov IV, Purkh T, Mohamed Fadi F, Paraska VI. [Hemodynamics, blood gas composition and viscosity in patients with chronic obstructive bronchitis complicated by chronic cor pulmonale]. Probl Tuberk Bolezn Legk. 2004(7):42\u201345. PMID:15387431."},{"key":"3827_CR34","unstructured":"Haider MZ, Anwer F. Secondary polycythemia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. PMID:32644485."},{"issue":"11","key":"3827_CR35","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1136\/thx.2008.112433","volume":"64","author":"R Yuan","year":"2009","unstructured":"Yuan R, Hogg JC, Par\u00e9 PD, Sin DD, Wong JC, Nakano Y, et al. Prediction of the rate of decline in FEV(1) in smokers using quantitative Computed Tomography. Thorax. 2009;64(11):944\u20139.","journal-title":"Thorax"},{"issue":"3","key":"3827_CR36","first-page":"326","volume":"8","author":"A Fawzy","year":"2021","unstructured":"Fawzy A, Woo H, Balasubramanian A, Barjaktarevic I, Barr RG, Bowler RP, et al. Polycythemia is Associated with Lower Incidence of Severe COPD Exacerbations in the SPIROMICS Study. Chronic Obstr Pulm Dis. 2021;8(3):326\u201335.","journal-title":"Chronic Obstr Pulm Dis"},{"issue":"1","key":"3827_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12890-021-01585-5","volume":"21","author":"J Zhang","year":"2021","unstructured":"Zhang J, DeMeo DL, Silverman EK, Make BJ, Wade RC, Wells JM, et al. Secondary polycythemia in chronic obstructive pulmonary disease: prevalence and risk factors. BMC Pulm Med. 2021;21(1):235.","journal-title":"BMC Pulm Med"},{"key":"3827_CR38","doi-asserted-by":"publisher","unstructured":"Kent BD, Mitchell PD, McNicholas WT. Hypoxemia in patients with COPD: cause, effects, and disease progression. Int J Chronic Obstr Pulm Dis. 2011;6:199\u2013208. https:\/\/doi.org\/10.2147\/COPD.S10611.","DOI":"10.2147\/COPD.S10611"},{"issue":"1","key":"3827_CR39","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1080\/15412555.2022.2053088","volume":"19","author":"JY Choi","year":"2022","unstructured":"Choi JY, Kim JW, Kim YH, Yoo KH, Jung KS, Lee JH, et al. Clinical Characteristics of Non-Smoking Chronic Obstructive Pulmonary Disease Patients: Findings from the KOCOSS Cohort. Copd. 2022;19(1):174\u201381.","journal-title":"Copd"},{"issue":"3","key":"3827_CR40","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3390\/mi13030357","volume":"13","author":"C Trejo-Soto","year":"2022","unstructured":"Trejo-Soto C, Hern\u00e1ndez-Machado A. Normalization of blood viscosity according to the hematocrit and the shear rate. Micromachines. 2022;13(3):357.","journal-title":"Micromachines"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03827-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03827-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03827-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:56:56Z","timestamp":1785826616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-026-03827-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3827"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03827-8","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of Konkuk University Hospital (IRB number: KUH1010338), which served as the main participating center, and by the Ethics Committee of each participating medical center. All participants provided written informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"300"}}